Astellas Pharma Inc. (FRA:YPH)
11.95
+0.27 (2.31%)
At close: Jan 9, 2026
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of €21.79 billion as of January 9, 2026. Its market cap has increased by 23.59% in one year.
Market Cap
21.79B
Enterprise Value
24.25B
Revenue
11.56B
Ranking
n/a
PE Ratio
30.30
Stock Price
€11.95
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 5.37B to 21.79B, an increase of 306.03%. That is a compound annual growth rate of 4.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 21.79B | 6.83% |
| Dec 30, 2025 | 20.39B | 21.07% |
| Dec 30, 2024 | 16.84B | -13.17% |
| Dec 29, 2023 | 19.40B | -25.24% |
| Dec 30, 2022 | 25.95B | -2.39% |
| Dec 30, 2021 | 26.58B | 13.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |